No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Viking, CRISPR, Intellia Among Potential M&A Targets: Wells Fargo
PTC Therapeutics Rallies 18% on EU Authorization Update for Translarna
Express News | Edgewise Therapeutics Inc : JP Morgan Raises Target Price to $27 From $24
Edgewise Therapeutics Inc (EWTX) Reports First Quarter 2024 Financial Results
Edgewise Therapeutics' New $175M Stock Sale Agreement and Previous Termination
Express News | Edgewise Therapeutics - Sales Agreement Prospectus Covering Offering of up to $175 Mln of Common Stock That May Be Issued Under Sales Agreement
The Real Wojak : Do you have like a top 3-5 that you like more than all the other ones? This list is way too long
72991267 : Glad I have some $Candel Therapeutics (CADL.US)$ after my disastrous SBFM.